Rationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study)
<p>Abstract</p> <p>Background</p> <p>Secondary treatment of arteriosclerosis may be applicable for the primary prevention of atherosclerosis in diabetic patients. This prospective, 2-year follow-up study was designed to determine the efficacy and safety of antiplatelet...
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
BMC
2006-08-01
|
| Serie: | Cardiovascular Diabetology |
| Länkar: | http://www.cardiab.com/content/5/1/16 |